„First Line“
Suchergebnisse
3.416 Treffer
-
Cost-effectiveness of the addition of CDK4/6 inhibitors to standard endocrine therapy in first-line treatment of women with advanced HR+/HER2− breast cancer in Mexico
-
First evidences of surfactant biodegradation by marine sponges (Porifera): an experimental study with a linear alkylbenzenesulfonate
-
Efficacy and safety of EGFR-TKIs in combination with angiogenesis inhibitors as first-line therapy for advanced EGFR-mutant non-small-cell lung cancer: a systematic review and meta-analysis
-
Risk of failing both methotrexate and mycophenolate mofetil from the First-line Antimetabolites as Steroid-sparing Treatment (FAST) uveitis trial
-
First-Line Therapy for Nodal T-cell Non-Hodgkin Lymphomas: an Unmet Need in Hematology
-
Impact of the first-line antiretroviral therapy on soluble markers of inflammation in cohort of human immunodeficiency virus type 1 in Moroccan patients: a prospective study
-
Determinants of adverse reactions to first-line antitubercular medicines: a prospective cohort study
-
Risk factors for thromboembolism during first-line treatment of patients with unresectable advanced or recurrent colorectal cancer: a retrospective short study
-
Linear convergence rate analysis of a class of exact first-order distributed methods for weight-balanced time-varying networks and uncoordinated step sizes
-
Plasma ESR1 mutations and outcome to first-line paclitaxel and bevacizumab in patients with advanced ER-positive/HER2-negative breast cancer
-
On first order congruences of lines in ℙ 4 with irreducible fundamental surface
-
Comparative cost-effectiveness of nivolumab first-line and second-line therapy for advanced esophageal cancer in Japan
-
Cost‑Effectiveness of Lorlatinib in First-Line Treatment of Adult Patients with Anaplastic Lymphoma Kinase (ALK)‑Positive Non‑Small‑Cell Lung Cancer in Sweden
-
Optimal sequencing of the first- and second-line target therapies in metastatic renal cell carcinoma: based on nationally representative data analysis from the Korean National Health Insurance System
-
What are the core recommendations for gout management in first line and specialist care? Systematic review of clinical practice guidelines
-
Numerical Simulation of Open‐Circuit Continuous Mills Using a Non‐Linear Population Balance Framework: Incorporation of Non‐First‐Order Effects †
-
Dolutegravir-associated resistance mutations after first-line treatment failure in Brazil
-
Immunotherapy for metastatic melanoma—from little benefit to first-line treatment
-
Patient-reported outcome (PRO)-based symptom assessment in patients with advanced lung cancer receiving first-line combination immunotherapy: a protocol for a multicenter, prospective, observational study
-
Real-world multicentre cohort of first-line pembrolizumab alone or in combination with platinum-based chemotherapy in non-small cell lung cancer PD-L1 ≥ 50%